| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L |
| P698 | PubMed publication ID | 12555668 |
| P50 | author | Oberdan Leo | Q95947194 |
| Fabienne Andris | Q114431487 | ||
| Jacques Urbain | Q6120921 | ||
| P2093 | author name string | Daniel Gigot | |
| Anthony Rongvaux | |||
| Martha H Mulks | |||
| Robin J Shea | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | niacinamide | Q192423 |
| P304 | page(s) | 3225-3234 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis | |
| P478 | volume | 32 |
| Q33915457 | "Clocks" in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging |
| Q28543172 | A H2S-Nampt dependent energetic circuit is critical to survival and cytoprotection from damage in cancer cells |
| Q46776529 | A key role for Pre-B cell colony-enhancing factor in experimental hepatitis |
| Q39259300 | A novel adipocytokine visfatin protects against H(2)O(2) -induced myocardial apoptosis: a missing link between obesity and cardiovascular disease |
| Q34454936 | A robust method for quantitative high-throughput analysis of proteomes by 18O labeling. |
| Q30384899 | A role for novel adipose tissue-secreted factors in obesity-related carcinogenesis. |
| Q34388776 | ARRB1/β-arrestin-1 mediates neuroprotection through coordination of BECN1-dependent autophagy in cerebral ischemia. |
| Q37791909 | Adipocyte–Brain: Crosstalk |
| Q33950766 | Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. |
| Q37845275 | Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases? |
| Q36972589 | Adipokines and insulin resistance |
| Q38357078 | Adipokines and their receptors: potential new targets in cardiovascular diseases. |
| Q38635208 | Adipokines in human reproduction. |
| Q38188874 | Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease |
| Q39256570 | Adipose crosstalk with other cell types in health and disease |
| Q28086997 | Adipose tissue, obesity and adipokines: role in cancer promotion |
| Q37594264 | An NAD(+) biosynthetic pathway enzyme functions cell non-autonomously in C. elegans development |
| Q40900460 | Analysis of the nicotinamide phosphoribosyltransferase family provides insight into vertebrate adaptation to different oxygen levels during the water-to-land transition |
| Q36771997 | Antitumor effect of combined NAMPT and CD73 inhibition in an ovarian cancer model |
| Q62764266 | Are all fats created equal? |
| Q37358220 | Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical update |
| Q36184224 | Association of Nicotinamide Phosphoribosyltransferase (NAMPT) Gene Polymorphisms and of Serum NAMPT Levels with Dilated Cardiomyopathy in a Chinese Population |
| Q34099865 | Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression |
| Q34500497 | Biogenesis and Homeostasis of Nicotinamide Adenine Dinucleotide Cofactor |
| Q64120074 | Biphasic Dynamics of Macrophage Immunometabolism during Infection |
| Q37151029 | CD73 protein as a source of extracellular precursors for sustained NAD+ biosynthesis in FK866-treated tumor cells |
| Q47978333 | CNS Targets of Adipokines |
| Q30912415 | Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. |
| Q35083117 | Cerebral ischemia is exacerbated by extracellular nicotinamide phosphoribosyltransferase via a non-enzymatic mechanism |
| Q42958361 | Circulating and local visfatin/Nampt/PBEF levels in spontaneously hypertensive rats, stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats. |
| Q47104399 | Combined Salt and Caloric Restrictions: Potential Adverse Outcomes |
| Q34563272 | Comparative genomics of NAD biosynthesis in cyanobacteria. |
| Q36913813 | Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes |
| Q30160291 | Crystal structure of a nicotinate phosphoribosyltransferase from Thermoplasma acidophilum |
| Q38635017 | Crystal structure-based comparison of two NAMPT inhibitors |
| Q38452980 | Cytoskeletal binding proteins distinguish cultured dental follicle cells and periodontal ligament cells |
| Q27937147 | Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans |
| Q38121170 | Diversification of NAD biological role: the importance of location |
| Q38405687 | EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells |
| Q37081323 | Effects of 12 weeks of combined exercise training on visfatin and metabolic syndrome factors in obese middle-aged women |
| Q55387036 | Elevated Nicotinamide Phosphoribosyl Transferase in Skeletal Muscle Augments Exercise Performance and Mitochondrial Respiratory Capacity Following Exercise Training. |
| Q24314812 | Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters |
| Q64076618 | Essential Role of Visfatin in Lipopolysaccharide and Colon Ascendens Stent Peritonitis-Induced Acute Lung Injury |
| Q39558774 | Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas. |
| Q54526365 | Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes. |
| Q90068896 | Extracellular nicotinate phosphoribosyltransferase binds Toll like receptor 4 and mediates inflammation |
| Q43165737 | Fasting promotes the expression of SIRT1, an NAD+ -dependent protein deacetylase, via activation of PPARalpha in mice. |
| Q26825012 | Forever young: SIRT3 a shield against mitochondrial meltdown, aging, and neurodegeneration |
| Q37346388 | From heterochromatin islands to the NAD World: a hierarchical view of aging through the functions of mammalian Sirt1 and systemic NAD biosynthesis |
| Q46516079 | Frontline Science: Tryptophan restriction arrests B cell development and enhances microbial diversity in WT and prematurely aging Ercc1-/Δ7 mice. |
| Q48617744 | Gene expression profiling of acute liver stress during living donor liver transplantation |
| Q57610656 | Gene expression signatures in chronic and aggressive periodontitis: a pilot study |
| Q34385910 | Genomics-driven reconstruction of acinetobacter NAD metabolism: insights for antibacterial target selection |
| Q28571563 | Growth phase-dependent changes in the subcellular localization of pre-B-cell colony-enhancing factor |
| Q41909845 | Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing. |
| Q37711085 | High-Intensity Exercise and Carbohydrate Supplementation do not Alter Plasma Visfatin |
| Q27664600 | High-Resolution Crystal Structures of Streptococcus pneumoniae Nicotinamidase with Trapped Intermediates Provide Insights into the Catalytic Mechanism and Inhibition by Aldehydes, |
| Q33946323 | Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation |
| Q34855293 | Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma |
| Q36950161 | Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients |
| Q57559188 | Increased levels and adipose tissue expression of visfatin in morbidly obese women: the relationship with pro-inflammatory cytokines |
| Q36409227 | Inflammatory mechanisms in the regulation of insulin resistance |
| Q33612522 | Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway |
| Q38703608 | Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma |
| Q53214701 | Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes. |
| Q36545914 | Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction |
| Q45918214 | Inhibition of pre-B cell colony-enhancing factor (PBEF/NAMPT/visfatin) decreases the ability of human neutrophils to generate reactive oxidants but does not impair bacterial killing. |
| Q39795774 | Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner |
| Q38668587 | Intracellular NAD+ levels are associated with LPS-induced TNF-α release in pro-inflammatory macrophages. |
| Q54313658 | Intracellular NAMPT-NAD+-SIRT1 cascade improves post-ischaemic vascular repair by modulating Notch signalling in endothelial progenitors. |
| Q38871980 | Intracellular nicotinamide adenine dinucleotide promotes TNF-induced necroptosis in a sirtuin-dependent manner |
| Q90040514 | Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models |
| Q34993305 | Is PBEF/visfatin/Nampt an authentic adipokine relevant to the metabolic syndrome? |
| Q91967761 | Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus |
| Q36849442 | Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity |
| Q37691630 | MC-PPEA as a new and more potent inhibitor of CLP-induced sepsis and pulmonary inflammation than FK866. |
| Q29614496 | Mammalian sirtuins: biological insights and disease relevance |
| Q37596160 | Mechanical stress induces pre-B-cell colony-enhancing factor/NAMPT expression via epigenetic regulation by miR-374a and miR-568 in human lung endothelium |
| Q45820449 | Mechanistic insights into the link between visfatin gene C-1535T polymorphism and coronary artery disease: an in vitro study |
| Q41348313 | Melatonin inhibits Sirt1-dependent NAMPT and NFAT5 signaling in chondrocytes to attenuate osteoarthritis |
| Q37745422 | Metabolic and molecular insights into an essential role of nicotinamide phosphoribosyltransferase |
| Q34539655 | Molecular basis for the inhibition of human NMPRTase, a novel target for anticancer agents. |
| Q28480662 | Molecular dynamics simulations suggest ligand's binding to nicotinamidase/pyrazinamidase |
| Q34481070 | Molecular processes during fat cell development revealed by gene expression profiling and functional annotation |
| Q38751073 | Monomeric eNAMPT in the development of experimental diabetes in mice: a potential target for type 2 diabetes treatment |
| Q37446707 | NAD and axon degeneration: from the Wlds gene to neurochemistry |
| Q28476267 | NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity |
| Q48025650 | NAD metabolism fuels human and mouse intestinal inflammation. |
| Q35805959 | NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus |
| Q36176007 | NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise |
| Q38667022 | NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism |
| Q49712935 | NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. |
| Q97643504 | NAD+ homeostasis in health and disease |
| Q36033195 | NAD+ levels control Ca2+ store replenishment and mitogen-induced increase of cytosolic Ca2+ by Cyclic ADP-ribose-dependent TRPM2 channel gating in human T lymphocytes |
| Q91691824 | NAD+ metabolism governs the proinflammatory senescence-associated secretome |
| Q36596234 | NAD+ utilization in Pasteurellaceae: simplification of a complex pathway. |
| Q30366556 | NAMPT and NAPRT1: novel polymorphisms and distribution of variants between normal tissues and tumor samples. |
| Q91713477 | NAMPT and NAPRT: Two Metabolic Enzymes With Key Roles in Inflammation |
| Q64070787 | NAMPT as a Dedifferentiation-Inducer Gene: NAD as Core Axis for Glioma Cancer Stem-Like Cells Maintenance |
| Q39889099 | NAMPT is essential for the G-CSF-induced myeloid differentiation via a NAD(+)-sirtuin-1-dependent pathway |
| Q40081111 | NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children |
| Q37183754 | Nampt is involved in DNA double-strand break repair. |
| Q24299618 | Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme |
| Q36536935 | Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? |
| Q48368351 | Nampt/PBEF/visfatin exerts neuroprotective effects against ischemia/reperfusion injury via modulation of Bax/Bcl-2 ratio and prevention of caspase-3 activation. |
| Q37334248 | Nampt: linking NAD biology, metabolism and cancer |
| Q41185582 | Neuronal protective role of PBEF in a mouse model of cerebral ischemia |
| Q42570229 | New plasmid tools for genetic analysis of Actinobacillus pleuropneumoniae and other pasteurellaceae |
| Q47858255 | Nicotinamide Phosphoribosyl Transferase a Reliable Marker of Progression in Cervical Dysplasia |
| Q36993938 | Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro |
| Q35581515 | Nicotinamide Phosphoribosyltransferase in Human Diseases |
| Q34003813 | Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery |
| Q90062246 | Nicotinamide and NAFLD: Is There Nothing New Under the Sun? |
| Q39247299 | Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells |
| Q33677954 | Nicotinamide mononucleotide attenuates brain injury after intracerebral hemorrhage by activating Nrf2/HO-1 signaling pathway. |
| Q27653693 | Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis |
| Q38836121 | Nicotinamide phosphoribosyltransferase (Nampt) in carcinogenesis: new clinical opportunities |
| Q37324960 | Nicotinamide phosphoribosyltransferase (Nampt): a link between NAD biology, metabolism, and diseases |
| Q45164914 | Nicotinamide phosphoribosyltransferase and lipid accumulation in macrophages |
| Q37424391 | Nicotinamide phosphoribosyltransferase in malignancy: a review |
| Q45914438 | Nicotinamide phosphoribosyltransferase is required for the calorie restriction-mediated improvements in oxidative stress, mitochondrial biogenesis, and metabolic adaptation. |
| Q34446797 | Nicotinamide phosphoribosyltransferase may be involved in age-related brain diseases |
| Q48054833 | Nicotinamide phosphoribosyltransferase production in human spermatozoa is influenced by maturation stage |
| Q34634272 | Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity |
| Q52717424 | Novel Protective Role of Nicotinamide Phosphoribosyltransferase in Acetaminophen-Induced Acute Liver Injury in Mice. |
| Q38956419 | Novel assay for simultaneous measurement of pyridine mononucleotides synthesizing activities allows dissection of the NAD(+) biosynthetic machinery in mammalian cells |
| Q24612868 | Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival |
| Q38005192 | PBEF/NAMPT/visfatin: a promising drug target for treating rheumatoid arthritis? |
| Q56987263 | Pathway analysis of NAD+metabolism |
| Q28575740 | Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide |
| Q33336612 | Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD |
| Q38555243 | Physiological and pathophysiological roles of NAMPT and NAD metabolism |
| Q34235614 | Plasma and myocardial visfatin expression changes are associated with therapeutic hypothermia protection during murine hemorrhagic shock/resuscitation. |
| Q37693027 | Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging |
| Q37216851 | Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions |
| Q36523324 | Pre-B cell colony enhancing factor (PBEF/NAMPT/Visfatin) and vascular endothelial growth factor (VEGF) cooperate to increase the permeability of the human placental amnion |
| Q38927815 | Pre-B cell colony enhancing factor induces Nampt-dependent translocation of the insulin receptor out of lipid microdomains in A549 lung epithelial cells |
| Q24568212 | Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis |
| Q24541303 | Pre-B-cell colony-enhancing factor is a secreted cytokine-like protein from the human amniotic epithelium |
| Q42119017 | Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity. |
| Q42640552 | Protective proteins and telomere length in placentas from patients with pre-eclampsia in the last trimester of gestation |
| Q38616779 | Protein acetylation in metabolism - metabolites and cofactors |
| Q36750433 | Protein deacetylation by SIRT1: an emerging key post-translational modification in metabolic regulation |
| Q36581224 | Quinolinate salvage and insights for targeting NAD biosynthesis in group A streptococci |
| Q91709275 | Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent |
| Q39195646 | Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin |
| Q27026075 | Regulation of cell survival and death by pyridine nucleotides |
| Q37448001 | Regulation of inflammatory cytokine expression in pulmonary epithelial cells by pre-B-cell colony-enhancing factor via a nonenzymatic and AP-1-dependent mechanism |
| Q35874520 | Regulation of poly(ADP-ribose) polymerase-1-dependent gene expression through promoter-directed recruitment of a nuclear NAD+ synthase |
| Q89640435 | Relationship between NAMPT/PBEF/visfatin and prognosis of patients with malignant tumors: a systematic review and meta-analysis |
| Q33932159 | Respected Sir(2): magic target for diabetes |
| Q37730290 | Review: NAD +: a modulator of immune functions |
| Q37497870 | Reviews: adipocytokines in normal and complicated pregnancies |
| Q59798260 | Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes |
| Q35588961 | SIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice |
| Q37625383 | SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions |
| Q90255200 | SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells |
| Q27934894 | Saccharomyces cerevisiae YOR071C encodes the high affinity nicotinamide riboside transporter Nrt1. |
| Q42546869 | Salidroside protects PC12 cells from Aβ1‑40‑induced cytotoxicity by regulating the nicotinamide phosphoribosyltransferase signaling pathway |
| Q28283588 | Sirtuin deacylases: a molecular link between metabolism and immunity |
| Q64272038 | Sirtuin signaling in cellular senescence and aging |
| Q37976307 | Sirtuins mediate mammalian metabolic responses to nutrient availability |
| Q36911415 | Sirtuins: the 'magnificent seven', function, metabolism and longevity |
| Q49836128 | Skeletal muscle overexpression of nicotinamide phosphoribosyl transferase in mice coupled with voluntary exercise augments exercise endurance. |
| Q34066630 | Stretch and inflammation-induced Pre-B cell colony-enhancing factor (PBEF/Visfatin) and Interleukin-8 in amniotic epithelial cells |
| Q37035805 | Stretching, mechanotransduction, and proinflammatory cytokines in the fetal membranes |
| Q27657748 | Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase |
| Q52571311 | Synthetic lethal and biochemical analyses of NAD and NADH kinases in Saccharomyces cerevisiae establish separation of cellular functions. |
| Q34413049 | Targeted, LCMS-based Metabolomics for Quantitative Measurement of NAD(+) Metabolites |
| Q92890445 | Targeting NAD immunometabolism limits severe graft-versus-host disease and has potent antileukemic activity |
| Q38790406 | Targeting Nicotinamide Phosphoribosyltransferase as a Potential Therapeutic Strategy to Restore Adult Neurogenesis. |
| Q89471669 | Targeting the NAD+ salvage pathway suppresses APC mutation-driven colorectal cancer growth and Wnt/β-catenin signaling via increasing Axin level |
| Q37700130 | The Determinants of Leptin Levels in Diabetic and Nondiabetic Saudi Males. |
| Q27671551 | The Leishmania nicotinamidase is essential for NAD+ production and parasite proliferation |
| Q34917651 | The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance |
| Q38047182 | The NAD metabolome--a key determinant of cancer cell biology |
| Q42171829 | The NAMPT inhibitor FK866 reverts the damage in spinal cord injury |
| Q38522653 | The Role of Nicotinamide Phosphoribosyltransferase in Cerebral Ischemia |
| Q26740177 | The cardiovascular impact of visfatin - an inflammation predictor biomarker in metabolic syndrome |
| Q90595734 | The chemistry of the vitamin B3 metabolome |
| Q80148396 | The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile |
| Q38242087 | The control of insulin secretion by adipokines: current evidence for adipocyte-beta cell endocrine signalling in metabolic homeostasis. |
| Q34623236 | The function of nicotinamide phosphoribosyltransferase in the heart. |
| Q34001681 | The novel adipocytokine visfatin exerts direct cardioprotective effects |
| Q64078872 | The potential influence of hyperthyroidism on circulating adipokines chemerin, visfatin, and omentin |
| Q54769886 | The role of visfatin on the regulation of inflammation and apoptosis in the spleen of LPS-treated rats. |
| Q37410764 | The small molecule GMX1778 is a potent inhibitor of NAD+ biosynthesis: strategy for enhanced therapy in nicotinic acid phosphoribosyltransferase 1-deficient tumors |
| Q37324972 | Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes |
| Q37799231 | Toward Productive Aging: SIRT1, Systemic NAD Biosynthesis, and the NAD World |
| Q41815804 | Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus |
| Q48176071 | Umbilical cord blood and maternal visfatin (PBEF/NAMPT) concentrations in preterm birth with and without preterm premature rupture of membranes |
| Q40080312 | VISFATIN (NAMPT) Improves In Vitro IGF1-Induced Steroidogenesis and IGF1 Receptor Signaling Through SIRT1 in Bovine Granulosa Cells |
| Q92503476 | Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis |
| Q59795800 | Visfatin Promotes Wound Healing through the Activation of ERK1/2 and JNK1/2 Pathway |
| Q46137989 | Visfatin and endogenous secretory receptor for advanced glycation end-products in diabetic type 2 and non-diabetic patients undergoing intermittent hemodialysis |
| Q35018928 | Visfatin as a novel mediator released by inflamed human endothelial cells |
| Q89413086 | Visfatin as a predictor for growth of fetus and infant |
| Q34071913 | Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity |
| Q39211254 | Visfatin is expressed in human granulosa cells: regulation by metformin through AMPK/SIRT1 pathways and its role in steroidogenesis |
| Q35244183 | Visfatin is induced by peroxisome proliferator-activated receptor gamma in human macrophages. |
| Q90005453 | Visfatin serum concentration and hepatic mRNA expression in chronic hepatitis C |
| Q55038680 | Visfatin/Nampt and SIRT1: Roles in Postterm Delivery in Pregnancies Associated With Obesity. |
| Q36970010 | Visfatin/Nampt: an adipokine with cardiovascular impact |
| Q42727741 | Visfatin/PBEF/Nampt: A New Cardiovascular Target? |
| Q36968586 | Visfatin/Pre-B cell colony-enhancing factor in amniotic fluid in normal pregnancy, spontaneous labor at term, preterm labor and prelabor rupture of membranes: an association with subclinical intrauterine infection in preterm parturition |
| Q90664709 | Visfatin/eNampt induces endothelial dysfunction in vivo: a role for Toll-Like Receptor 4 and NLRP3 inflammasome |
| Q36217233 | Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis |
| Q34613425 | Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions |
| Q46645132 | Visfatin: New marker of oxidative stress in preterm newborns. |
| Q37690440 | Visfatin: a potential therapeutic target for rheumatoid arthritis |
Search more.